Pharmacokinetics, biodistribution and bioavailability of isoliquiritigenin after intravenous and oral administration

References

• Akaike A. (1986). An information criterion (AIC). Math Sci 14:5–9
   Google Scholar
• Baba M, Asano R, Takigami I, et al. (2002). Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis. Biol Pharm Bull 25:247–50
   PubMedGoogle Scholar
• Cao Y, Wang Y, Ji C, Ye J. (2004). Determination of liquiritigenin and isoliquiritigenin in Glycyrrhiza uralensis and its medicinal preparations by capillary electrophoresis with electrochemical detection. J Chromatogr A 1042:203–9
   PubMedGoogle Scholar
• Chan SC, Chang YS, Wang JP, et al. (1998). Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med 64:153–8
   PubMed Web of Science ®Google Scholar
• Chin YW, Jung HA, Liu Y, et al. (2007). Antioxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra). J Agric Food Chem 55:4691–7
   PubMed Web of Science ®Google Scholar
• Chisato N, Yang J, Kazuho S, et al. (2008). Inhibitory effects of isoliquiritigenin and licorice extract on voltage-dependent K+ currents in H9c2 cells. J Mol Cell Cardiol 44:444–61
   Google Scholar
• Chowdhury SA, Kishino K, Satoh R, et al. (2005). Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res 25:2055–63
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1009–95
   Web of Science ®Google Scholar
• FDA. (2001). US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation
   Google Scholar
• Gibaldi M, Perrier D. (1982). Non-Compartmental Analysis Based on Statistical Moment Theory. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 409–17
   Google Scholar
• Godfrey KR, Arundel PA, Dong ZM, Bryant R. (2011). Modelling the double peak phenomenon in pharmacokinetics. Comput Meth Prog Bio 104:62–9
   PubMed Web of Science ®Google Scholar
• Granero GE, Amidon GL. (2008). Possibility of enterohepatic recycling of ketoprofen in dogs. Int J Pharm 349:166–71
   PubMed Web of Science ®Google Scholar
• Haraguchi H, Ishikawa H, Mizutani K, et al. (1998). Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflate. Bioorg Med Chem 6:339–47
   PubMed Web of Science ®Google Scholar
• Hsu YL, Kuo PL, Lin CC. (2005a). Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells. Life Sci 77:279–92
   PubMed Web of Science ®Google Scholar
• Hsu YL, Kuo PL, Lin LT, Lin CC. (2005b). Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med 71:130–4
   PubMed Web of Science ®Google Scholar
• Hua X, Fu YJ, Zu YG, et al. (2010). Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal 52:273–9
   PubMedGoogle Scholar
• Ii T, Satomi Y, Katoh D, et al. (2004). Induction of cell cycle arrest and p21(CIP1/WAF1) expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 207:27–35
   PubMed Web of Science ®Google Scholar
• Iwashita K, Kobori M, Yamaki K, Tsushida T. (2000). Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 64:1813–20
   PubMed Web of Science ®Google Scholar
• Jung JI, Chung E, Seon MR, et al. (2006a). Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. Biofactors 28:159–68
   PubMedGoogle Scholar
• Jung JI, Lim SS, Choi HJ, et al. (2006b). Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem 17:689–96
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Satomi Y, Mizutani Y, et al. (2003). Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 43:580–6
   PubMed Web of Science ®Google Scholar
• Kape R, Parniske M, Brandt S, Werner D. (1992). Isoliquiritigenin a strong nod gene- and glyceollin resistance-inducing flavonoid from soybean root exudate. Appl Environ Microb 58:1705–10
   PubMed Web of Science ®Google Scholar
• Kim DC, Choi SY, Kim SH, et al. (2006). Isoliquiritigenin selectively inhibits H2 histamine receptor signaling. Mol Pharmacol 70:493–500
   PubMedGoogle Scholar
• Kim JY, Park SJ, Yun KJ, et al. (2008). Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur J Pharmacol 584:175–84
   PubMed Web of Science ®Google Scholar
• Kim SC, Byun SH, Yang CH, et al. (2004). Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage). Toxicol 197:239–51
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Miyamoto T, Kimura I, Kimura M. (1995). Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro. Biol Pharm Bull 18:2–6
   Google Scholar
• Lainesse C, Frank D, Meucci V, et al. (2006). Pharmacokinetics of clomipramine and desmethylclomipramine after single-dose intravenous and oral administration in cats. J Vet Pharmacol Ther 29:271–8
   PubMed Web of Science ®Google Scholar
• Li DQ, Wang Q, Yuan ZF, et al. (2008). Pharmacokinetics and tissue distribution study of orientin in rat by liquid chromatography. J Pharm Biomed Anal 47:429–34
   PubMed Web of Science ®Google Scholar
• Ma J, Fu NY, Pang DB, et al. (2001). Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med 67:754–7
   PubMed Web of Science ®Google Scholar
• Maggiolini M, Statti G, Vivacqua A, et al. (2002). Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol 82:315–22
   PubMed Web of Science ®Google Scholar
• Morteza SK, Saeedi M, Hamidian M. (2004). Anti-inflammatory and analgesic activity of the topical preparation of Glaucium grandiflorum. Fitoterapia 75:123–9
   PubMedGoogle Scholar
• Mostafavi SA, Foster RT. (2003). Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: The effect of gastric pH on double-peak phenomena. Int J Pharm 255:81–6
   PubMedGoogle Scholar
• Piyapolrungroj N, Zhou YS, Li C, et al. (2000). Cimetidine absorption and elimination in rat small intestine. Drug Metab Dispos 28:65–72
   PubMed Web of Science ®Google Scholar
• Takahashi T, Takasuka N, Iigo M, et al. (2004). Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 95:448–53
   PubMed Web of Science ®Google Scholar
• Tamir S, Eizenberg M, Somjen D, et al. (2001). Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol 78:291–8
   PubMed Web of Science ®Google Scholar
• Tawata M, Aida K, Noguchi T, et al. (1992). Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol 212:87–92
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Aizu E, Jiang H, et al. (1991). The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis 12:317–23
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Nakagawa T, Uno T. (1978). Statistical moment in pharmacokinetics. J Pharm Biopharm 6:547–58
   PubMedGoogle Scholar
• Yamazaki S, Morita T, Endo H, et al. (2002). Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett 183:23–30
   PubMed Web of Science ®Google Scholar
• Yin OQ, Tomlinson B, Chow AH, Chow MS. (2003). A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine. Clin Pharmacokinet 42:179–92
   PubMedGoogle Scholar
• Zhang XY, Liu JP, Qiao H, et al. (2009). Determination and pharmacokinetics of isoliquiritigenin in rat plasma by reverse phase high-performance liquid chromatography after intravenous administration. Chromatographia 70:423–30
   Web of Science ®Google Scholar